During this SWHR town hall event, heard from speakers about how individuals across communities can take steps to prepare for Alzheimer's and how organizations and policymakers alike are taking steps to improve Alzheimer's outcomes and reach diverse and underserved communities.
This event discussed how to improve health outcomes for individuals with psoriatic arthritis through recognizing and addressing symptoms, comorbidities, treatment options, and barriers to accessing quality care, while highlighting the diverse experiences of women across the lifespan.
SWHR convened an interdisciplinary HPV Vaccine Education Working Group of public health researchers and professionals, community leaders, and health care providers to discuss how to eliminate barriers to HPV vaccine confidence, access, and uptake through the development of educational materials designed to reach women.
SWHR’s Policy Advisory Council will meet for its quarterly closed-door meeting. The Policy Advisory Council is a forum for industry, […]
The event discusses how to improve health outcomes for individuals with lupus through recognizing and addressing symptoms, comorbidities, treatment options, and barriers to accessing quality care, while highlighting the diverse experiences of women living with lupus.
During this virtual congressional briefing and national webinar, panelists reviewed ethical considerations surrounding inclusion of pregnant and lactating women in research, how to ensure the appropriate inclusion of these populations, and the current state of this type of inclusion in research, both within the federal government and the corporate sector.
During this public forum, panelists discussed the disproportionate impact of autoimmune diseases and conditions on women and why tackling autoimmune diseases and conditions should be a federal priority. Following the discussion, panelists also reviewed SWHR’s newly launched autoimmune disease policy agenda.
During this congressional briefing and national webinar, panelists explored certain areas of research where the exclusion of these groups has resulted in an inability to support them, how federal research investments could improve outcomes, and where there is opportunity—both at the legislative and regulatory level—moving forward.
In this webinar, panelists reviewed coverage and access issues that could negatively affect those with autoimmune diseases and conditions, the tenants of prior authorization and step therapy, discuss the role these policies can play in patient outcomes and on providers, and how current policies could be modified to better serve individuals.
SWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. This events will discuss how to improve health outcomes for diseases and conditions that differently affect women, with a focus on heart disease.
